Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Pain mapping may unlock personalized treatment for chronic pancreatitis

NCT ID NCT03434392

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 11, 2026 · Updated 1 time

Summary

This study uses a technique called Quantitative Sensory Testing (QST) to understand different pain patterns in people with chronic pancreatitis. By mapping how the nervous system processes pain, researchers hope to predict which patients will benefit from specific treatments like endoscopic procedures. The study involves 500 participants and aims to improve treatment decisions and outcomes for this painful condition.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2017

Expected to finish

Jun 2031

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Subjects with no pancreatic disease and no abdominal pain, or patients with a diagnosis of functional dyspepsia. * Subjects are 18 years or older in age * Subjects must be able to read and understand the study information. * Personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study. * Subject is willing and able to comply with the scheduled visits, questionnaires, treatment plan, and other study procedures. 2. Suspected CPs Inclusion Criteria * Subjects are 18 years or older in age * Subjects with a) Indeterminate CP (Cambridge 1 or 2 on CT scan or MRI/MRCP) who have abdominal pain without prior history of AP, or b) those with acute (AP) or recurrent acute pancreatitis (RAP) who have recovered from their attack(s) of AP, whose imaging studies are either normal or show changes consistent with Cambridge classification of 1 or 2, and they have ongoing abdominal pain. Both diabetic and non-diabetic subjects will be allowed to enter the study. * Subjects must be able to read and understand the study information. * Subjects must suffer from abdominal pain suspected to be pancreatic origin with an intensity above 3 on the visual analogue scale (VAS, where 0=no pain and 10= intolerable pain), and meet the criteria for chronic pain (pain ≥ 3 days per week for at least 3 months). * Personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study. * Subjects willing and able to comply with the scheduled visits, questionnaires, and other study procedures. 3. Definite Chronic Pancreatitis - Inclusion Criteria * Subjects are 18 years or older in age * Subjects will have a prior confirmed diagnosis of CP on CT scan or MRI/MRCP according to Cambridge Classification (grade 3 or 4). Both diabetic and non-diabetic subjects will be allowed to enter the study. * Subjects must be able to read and understand the study information. * Personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study. * Subjects willing and able to comply with the scheduled visits, questionnaires, and other study procedures. 4. Sphincter of Oddi Dysfunction (SOD) Type 1 or Type 2 Inclusion Criteria * Subjects are 18 years or older in age * Subjects have prior diagnosis of Type 1 or Type 2 Sphincter of Oddi Dysfunction (subjects with biliary pain accompanied by biochemical features of transient biliary tract obstruction including elevated transaminases, alkaline phosphatase, or conjugated bilirubin; may also be accompanied by biliary or pancreatic ductal dilation on imaging) * Subjects must be able to read and understand the study information. * Personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study. * Subjects willing and able to comply with the scheduled visits, questionnaires, and other study procedures. Exclusion Criteria: 1. Subjects with no pancreatic disease and no abdominal pain, or patients with a diagnosis of functional dyspepsia. * Subjects with evidence or history of medical or surgical disease of importance for this study as judged by investigator. * Subjects suffering from painful conditions that make them unable to distinguish the pain associated with CP from chronic pain of other origins. * Subjects with known pregnancy at the time of enrolment. * Subjects who have previously undergone surgical intervention on their pancreas. 2. Suspected CPs Exclusion Criteria * Subjects with evidence or history of medical or surgical disease of importance for this study as judged by investigator. * Subjects suffering from painful conditions other than pancreatitis or SOD type 1 or 2 that make them unable to distinguish the pain associated with pancreatitis or SOD from chronic pain of other origins. * Subjects with known pregnancy at the time of enrolment. * Subjects who have previously undergone surgical intervention on their pancreas. 3. Definite Chronic Pancreatitis Exclusion Criteria * Subjects with evidence or history of medical or surgical disease of importance for this study as judged by investigator. * Subjects suffering from painful conditions other than pancreatitis or SOD type 1 or 2 that make them unable to distinguish the pain associated with pancreatitis or SOD from chronic pain of other origins. * Subjects with known pregnancy at the time of enrolment. * Subjects who have previously undergone surgical intervention on their pancreas. 4. Sphincter of Oddi Dysfunction (SOD) Type 1 or Type 2 Exclusion Criteria * Subjects with evidence or history of medical or surgical disease of importance for this study as judged by investigator. * Subjects suffering from painful conditions other than pancreatitis or SOD that make them unable to distinguish the pain associated with pancreatitis or SOD from chronic pain of other origins. * Subjects with known pregnancy at the time of enrolment. * Subjects who have previously undergone surgical intervention on their pancreas.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Johns Hopkins Medical Institutions

    RECRUITING

    Baltimore, Maryland, 21287, United States

  • University of Pittsburgh Medical Center

    RECRUITING

    Pittsburgh, Pennsylvania, 15213, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.